1. Home
  2. KEX vs PRAX Comparison

KEX vs PRAX Comparison

Compare KEX & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kirby Corporation

KEX

Kirby Corporation

HOLD

Current Price

$143.32

Market Cap

7.6B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$343.64

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEX
PRAX
Founded
1921
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
9.0B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
KEX
PRAX
Price
$143.32
$343.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
15
Target Price
$137.25
$572.13
AVG Volume (30 Days)
606.7K
332.8K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
28.92
N/A
EPS
1.50
N/A
Revenue
N/A
N/A
Revenue This Year
$4.34
N/A
Revenue Next Year
$7.61
$7,758.26
P/E Ratio
$96.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$79.52
$35.21
52 Week High
$157.69
$358.76

Technical Indicators

Market Signals
Indicator
KEX
PRAX
Relative Strength Index (RSI) 47.62 55.46
Support Level $140.14 $282.49
Resistance Level $157.69 $353.86
Average True Range (ATR) 3.85 20.50
MACD -0.50 0.17
Stochastic Oscillator 36.30 71.68

Price Performance

Historical Comparison
KEX
PRAX

About KEX Kirby Corporation

Kirby Corp is a domestic tank barge operator, transporting bulk liquid products throughout three United States coasts. The Company transports petrochemicals, liquid cargoes, inland waterway systems, and dry bulk cargoes. The Company conducts operations in two reportable business segments: The Marine transportation segment which provides marine transportation services, operating tank barges and towing vessels transporting bulk liquid products, and the Distribution and services segment, which provides after-market service, and genuine replacement parts for engines, transmissions, reduction gears, and power generation equipment used in oil and gas and commercial and industrial applications. The company's majority revenue is generated from the Marine Transportation segment.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: